losartan has been researched along with Cholera Infantum in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| "Losartan is an angiotensin II receptor antagonist that is metabolized by CYP2C9 and CYP3A4 to a more potent antihypertensive metabolite, E3174." | 2.69 | The effects of fluvastatin, a CYP2C9 inhibitor, on losartan pharmacokinetics in healthy volunteers. ( Hinderliter, AL; Meadowcroft, AM; Patterson, JH; Pieper, JA; Williamson, KM, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meadowcroft, AM | 1 |
| Williamson, KM | 1 |
| Patterson, JH | 1 |
| Hinderliter, AL | 1 |
| Pieper, JA | 1 |
1 trial available for losartan and Cholera Infantum
| Article | Year |
|---|---|
The effects of fluvastatin, a CYP2C9 inhibitor, on losartan pharmacokinetics in healthy volunteers.
Topics: Adolescent; Adult; Antihypertensive Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Blood P | 1999 |